The emergence of SARS-CoV-2 led to pandemic spread of coronavirus disease 2019 (COVID-19),
manifesting with respiratory symptoms and multi-organ dysfunction. Detailed …

Objective Chronic HBV infection affects more than 250 million people worldwide and remains
a global healthcare problem in part because we lack curative treatment. Sustained viral …

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…

Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …

INTRODUCTION The clinical manifestations of COVID-19 vary from asymptomatic infection
to respiratory failure. Severe disease courses are primarily associated with advanced age, …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern (VOC)
resists neutralization by major classes of antibodies from COVID-19 patients and …

Health-care workers were enrolled at Charité-Universitätsmedizin Berlin (n= 107) and older
people were enrolled at an assisted living facility in Berlin, Germany (n= 82).(A) Anti-S1 IgG …

Convalescent plasma is plasma collected from individuals after resolution of an infection
and the development of antibodies. Passive antibody administration by transfusion of …

Oligosaccharide Mass Profiling (OLIMP) allows a fast and sensitive assessment of cell wall
polymer structure when coupled with Matrix Assisted Laser Desorption Ionisation Time Of …

Patients with kidney failure have notoriously weak responses to common vaccines. Thus,
immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine …